Veraxa Biotech Holding AG (VRXA) vs Voyager Therapeutics, Inc. (VYGR)
A side-by-side comparison of Veraxa Biotech Holding AG and Voyager Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
VRXA
Veraxa Biotech Holding AG
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VYGR
Voyager Therapeutics, Inc.
$2.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — VRXA vs VYGR
growth of $100 · dividends reinvested · last 1yVRXA -90.8% (-90.8%/yr)VYGR -40.3% (-40.3%/yr)VYGR compounded faster over this window
Log scale — wide-divergence pair
VRXA VYGR
Metrics side by side
Total return (annualized)
| Metric | VRXA | VYGR |
|---|---|---|
| Total return (1Y) | N/A | -49.22% |
| Total return CAGR (3Y) | N/A | -30.09% |
| Total return CAGR (5Y) | N/A | -0.08% |
| Total return CAGR (10Y) | N/A | -14.87% |
VRXA is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.